Camp4 Therapeutics Q3 EPS $(0.37) Misses $(0.18) Estimate, Sales $1.899M Beat $1.850M Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings BeatsEarnings Misses
Camp4 Therapeutics (NASDAQ:CAMP) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.18) by 105.56 percent. This is a 32.73 percent increase over losses of $(0.55) per share
Camp4 Therapeutics (NASDAQ:CAMP) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.18) by 105.56 percent. This is a 32.73 percent increase over losses of $(0.55) per share from the same period last year. The company reported quarterly sales of $1.899 million which beat the analyst consensus estimate of $1.850 million by 2.65 percent. This is a 138.87 percent increase over sales of $795.000 thousand the same period last year.